Drug intelligence / Profile preview

essiac

Development stage
Discontinued
Lead developer
Rene Caisse
Administration
Oral
01

Overview

Essiac is a proprietary herbal mixture originally popularized in the 1920s by Canadian nurse Rene Caisse (the name "Essiac" is her surname spelled backwards). It consists of four main herbs: burdock root (Arctium lappa), sheep sorrel (Rumex acetosella), slippery elm inner bark (Ulmus fulva or Ulmus rubra), and Indian rhubarb root (Rheum palmatum). Some later formulations—such as Flor-Essence—add watercress, blessed thistle, red clover, and kelp. Essiac is marketed as a dietary supplement and herbal tea with claims that it can detoxify the body, strengthen the immune system, relieve pain, reduce tumor size or side effects from cancer treatment, improve quality of life and energy levels, and promote general well-being. However, there is no scientific evidence supporting its efficacy for treating cancer or any other disease; some studies have shown no benefit or even potential harm. The product has not been approved by regulatory agencies such as the FDA for any medical use[1][2][3][4][5][6][7].

Brand names
Essiac
Other names
Flor-EssenceHerbal EssenceNAP Herbal TeaTea of LifeVitalitea
02

Targets

CYP2C19 (Cytochrome P450 2C19)CYP1A2 (Cytochrome P450 1A2)

Beyond the preview

Go deeper on essiac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on essiac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call